medigraphic.com
ISSN 1561-2996 (Digital)
ISSN 0864-0289 (Impreso)

2015, Número 1

<< Anterior Siguiente >>

Rev Cubana Hematol Inmunol Hemoter 2015; 31 (1)


Trali, una amenaza enmascarada: definición, aspectos epidemiológicos y clínicos

Román TR, Fernández DND

Idioma: Español
Referencias bibliográficas: 43
Paginas: 4-19
Archivo PDF: 135.70 Kb.


RESUMEN

El daño pulmonar agudo relacionado con la transfusión o TRALI, como más comúnmente se le conoce, por definición no se diferencia de otros tipos de distrés respiratorios, salvo por su origen demostrable y su estrecha relación temporal con la transfusión. Constituye una de las reacciones adversas más peligrosas del uso de productos sanguíneos y sus peculiares características le permiten enmascararse entre los muchos factores que pueden desencadenar un daño pulmonar agudo, especialmente en algunos pacientes que resultan más susceptibles a su desarrollo. El propósito de esta revisión es hacer un recordatorio de su existencia, sobre todo a aquellos médicos que manejan cotidianamente pacientes demandantes de componentes sanguíneos y cuya condición clínica favorece su aparición. Sus principales variables epidemiológicas (ej: incidencia y mortalidad) varían, a veces de manera notable, entre los distintos informes. La heterogeneidad de criterios aun después de la consecución de consensos internacionales para su diagnóstico, dificulta aprovechar al máximo los datos obtenidos de los distintos estudios realizados sobre su comportamiento y ha promovido la aparición de no pocos resultados contradictorios. Su diagnóstico clínico representa un reto al presentarse en medio de contextos clínicos que hacen plantear otras causas para la aparición del distrés respiratorio. Por ello, muchas veces pasa inadvertido o es mal identificado.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Benjamin RJ. Tracking TRALI in target populations. Blood. 2011;117(16):4163-4. doi:10.1182/blood-2011-03-338913.

  2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet. 1967;2:319-23.

  3. Triulzi DJ. Transfsion-Related Acute Lung Injury: Current Concepts for the Clinician. J Anest Analg. 2009; 108(3):770-6. doi: 10.1213/ane.0b013e31819029b2.

  4. Popovsky MA, Abel MD, Moore SB. Transfusion related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Resp Dis. 1983;128:185-9.

  5. Popovsky MA, Moore SB. Diagnostic and pathogenic consideration in transfusion- -related acute lung injury. Transfusion. 1985;25:573-7.

  6. Ozier Y, Muller JY, Mertes PM, Renaudier P, Aguilon P, Canivet N, et al. Transfusionrelated acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion. 2011;51:2102-10. doi: 10.1111/j.1537-2995.2011.03073.x

  7. Bernard GR, Artigas A, Brigham KL. The American-European concensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3):818-24.

  8. Añón JM, García de Lorenzo A, Quintana M, González E, Bruscas M. Lesión pulmonar aguda producida por transfusión. Med Intens. 2010;34(2):139-49. doi: 10.1016/i.medin.2009.03.007

  9. Müller MCA, Juffermans NP. Transfusion-related acute lung injury: a preventable syndrome? Expert Rev Hematol. 2012;5(1):97-106.

  10. Kleinman S, Caufield T, Chan P, Davenport R, McFarland J, McPhedran S, et al. Toward an understanding of transfusion-related acute lung injury: statements of a consensus panel. Transfusion. 2004;44:1774-89.

  11. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards and understanding of TRALI. Transfus Med Rev. 2005;19:2-31.

  12. Carcano C, Okafor N, Martínez F, Ramírez J, Kanne J, Kirsch J. Radiographic manifestations of transfusion-related acute lung injury. Clin Imaging. 2013 Nov- Dec;37(6):1020-3. doi: 10.1016/j.clinimag.2013.06.008

  13. Moore SB. Transfusion-related acute lung injury (TRALI). Clinical presentation, treatment and prognosis. Crit Care Med. 2006;34(5):114-7.

  14. Marik PE, Corwin HL. Acute lung injury following to transfusion: Expanding the definition. Crit Care Med. 2008;36:3080-4.

  15. Toy P, Gajic O, Bachetti P, Looney MR, Grooper MA, Hubmayr RD; for the TRALI Study Group. Transfusion-related acute lung injury: incidence and risk factors. Blood. 2012;119(7):1757-67.

  16. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al; for the Clinical Transfusion Medicine Committee of the AABB. Red Blood Cell Transfusion; A Clínical Practice Guideline From the AABB. Ann Intern Med. 2012;157(1):49-58.

  17. Gajic O, Rana R, Winters J, Yilmaz M, Mendez JL, Rickman OB, et al. Transfusion-related acute lung injury in the critically ill: prospective nested case control study. Ann J Respir Crit Care Med. 2007;176:886-91.

  18. Keller-Stanislawski B, Reil A, Günay S, Funk MB. Frequency and severity of transfusion-related acute lung injury-German hemovigilance data (2006-2007). Vox Sang. 2010;98:70-7. doi:10.1111/j.1423-0410.2009.01232.x.

  19. Funk MB, Günay S, Lohmann A, Henseler O, Heiden M, Hanschmann KMQ, et al. Benefit of transfusion-related acute lung injury risk-minimization measures-German hemovigilance data (2006-2010).Vox Sang. 2012;102:317-323. doi:10.1111/j.1423-0410.2011.01556.x.

  20. Shaz BH. Giving TRALI the one-two punch. Blood. 2012;119(7):1620-1. doi: 10.1182/blood-2011-12-395897.

  21. Rizk A, Gorson KC, Keney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion. 2001;41:264-8.

  22. Win N, Chapman CE, Bowles KM, Green A, Bradley S, Edmondson D, et al. How much residual plasma may cause TRALI? Transf Med. 2008;18:276-80. doi:10.1111/j.1365-3148-2008.00885.x.

  23. Vlaar AP, Hofstra JJ, Levi M. Supernatant of aged erythrocytes causes lung inflammation and coagulopathy in a `two hit´ in vivo syngeneic transfusion model. Anesthesiology. 2010;13(1):92-103.

  24. Benson AB, Austin GL, Berg M. Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding. Intensive Care Med. 2010;36(10):1710-7.

  25. Vlaar AP, Bimekade JM, Prins D, van Stein D, Hofstra JJ, Schultz MJ, et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: a nested case-control study. Crit Care Med. 2010;38:771-8.

  26. Sánchez Padrón A, Sánchez Valdivia A, Fernández Morín J. Distrés respiratorio agudo y embarazo: algunos aspectos de interés. Rev Cubana Obstet Ginecol [revista en la Internet]. 2006 Dic [citado 2014 Feb 09];32(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138- 600X2006000300003&lng=es

  27. Catanzarite V, Willms D, Wong D, Landers C, Cousins L, Schrimmer D. Acute respiratory distress syndrome in pregnancy and the puerperium: causes, course and outcome. Obstet Gynecol. 2001;97(5):760-4.

  28. Pérez Zamora LR, Montero Alvarez R, Martin Pérez R. Nivel de conocimientos sobre la transfusión en médicos de las especialidades quirúrgicas del Hospital General de Morón “Roberto Rodríguez Fernández”. MediCiego [revista en la Internet] 2007[citado 2014 Feb 09];13(1). Disponible en: http://bvs.sld.cu/revistas/mciego/vol13_01_07/articulos/a14_v13_0107.htm

  29. Stronceck DF. Hot on the trail of TRALI. Blood. 2006;108(7):2136-7. doi:10.1182/blood-2006-07-034736.

  30. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a cofactor in the development of transfusion-related acute lung injury. Blood. 2006;108(7):2455-62. doi:10.1182/blood-2006-07-034736.

  31. Silliman CC, Moore SB, Kelher MR, Khan SY, Gellar L, Elzi DJ. Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion. 2011;51(12):2549-54.

  32. Haji AG, Sharma S, Vijaykumar DK, Paul J. Transfusion related acute lung injury presenting with acute dispnoea: a case report. J Med Case Rep. 2008;2:336. doi:10.1186/1752-1947-2-336.

  33. Juffermans NP. Transfusion-related acute lung injury: emerging importance of host factors and implications for management. Expert Rev Hematol. 2010;3(4):459-67.

  34. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105:2266-73. doi:10.1182/blood-2004-07-2929.

  35. Zhou L, Giacherio D, Cooling L, Davenport RD. Use of B-natriuretic peptide as diagnostic marker in the differential diagnosis of transfusión-associated circulatory overload. Transfusion. 2005;45:1056-63.

  36. Nakagawa M, Toy P. Acute and transient decrease in neutrophil count in transfusión-related acute lung injury: cases at one hospital. Transfusion. 2004;44:1689-94.

  37. Murphy MF, Navarrete C, Massey E. Donor screening as a TRALIL risk reduction strategy. Transfusion. 2009;49:1779-82.

  38. Kleinman S, Triulzi DJ, Murphy EL, Carey PM, Gottschall JL, Roback JD, et al; for the National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study-II (REDS-II). The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody-positive or –negative components. Transfusion. 2011;51:2078-91. doi:10.1111/j.1537-2995.2011.03120.x

  39. Reil A, Keller-Stanislawski B, Günay S, Bux J. Specificities of leukocyte alloantibodies in transfusion-related acute lung injury and results of leukocyte antibody screening of blood donors. Vox Sang. 2008;95:313-7.

  40. Quillen K, Medrano C, Adams S, Peterson B, Hackett J, Leitman SF, et al. Screening plateletpheresis donors for HLA antibodies on two high throughput platforms and correlation with recipient outcome. Transfusion. 2011;51:504-10.

  41. Davoreen A, Curtis BR, Schulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a(5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion. 2003;43:641-5.

  42. Caudrillier A, Kessenbrock K, Gillis BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012;122(7):2661-71.

  43. Chapman CE, Stainsley D, Jones H, Love E, Massey E, Win N, et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kindom, and the impact of preferential use of male donor plasma. Transfusion. 2009;49:440-52.




2020     |     www.medigraphic.com